InvestorsHub Logo
Followers 47
Posts 12038
Boards Moderated 0
Alias Born 09/12/2017

Re: misiu143 post# 230042

Saturday, 02/24/2024 12:56:05 PM

Saturday, February 24, 2024 12:56:05 PM

Post# of 232961
And EUA is not the same as approval , that what should be given , and lives would be saved !!!!!!

CYDY never applied for EUA even though they released a PR to the public stating they DID right?

RIGHT?

CytoDyn Submits its Top-line Report from its Phase 2 COVID-19 Trial to the U.S. FDA and Requests Emergency Use Approval
Press Release | 08/17/2020
The Top-line Report has been sent to the regulatory authorities in Mexico, and will be provided to U.K. MHRA, and E.U. EMA, with requests for emergency use approval

CytoDyn is preparing a Phase 3 protocol for leronlimab use in long-hauler COVID-19 individuals

VANCOUVER, Washington, Aug. 17, 2020 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company announced today it has provided its Top-line Report from its recently completed, randomized, double-blind, Phase 2 trial for COVID-19 patients with mild-to-moderate symptoms to the U.S. Food and Drug Administration (FDA), and requested emergency use approval.
https://www.otcmarkets.com/stock/CYDY/news/CytoDyn-Submits-its-Top-line-Report-from-its-Phase-2-COVID-19-Trial-to-the-US-FDA-and-Requests-Emergency-Use-Approval?id=271007

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News